Evommune EVMN Fair Value Adjustment Decreasing Derivative Liability
Fair Value Adjustment Decreasing Derivative Liability at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:FairValueAdjustmentDecreasingDerivativeLiability.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's fair value adjustment decreasing derivative liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Evommune 's fair value adjustment decreasing derivative liability?
- Evommune (EVMN) reported fair value adjustment decreasing derivative liability of $1.84M in Q4 2025.
- What does fair value adjustment decreasing derivative liability mean?
- Represents the non-cash gain recognized when the fair value of derivative liabilities decreases, often due to changes in market conditions or the company's stock price. This adjustment impacts net income without affecting immediate cash flow. It is critical for understanding the volatility of the company's balance sheet and non-operating income.